These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21312262)

  • 41. UPD detection using homozygosity profiling with a SNP genotyping microarray.
    Papenhausen P; Schwartz S; Risheg H; Keitges E; Gadi I; Burnside RD; Jaswaney V; Pappas J; Pasion R; Friedman K; Tepperberg J
    Am J Med Genet A; 2011 Apr; 155A(4):757-68. PubMed ID: 21594998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reliable high-throughput genotyping and loss-of-heterozygosity detection in formalin-fixed, paraffin-embedded tumors using single nucleotide polymorphism arrays.
    Lips EH; Dierssen JW; van Eijk R; Oosting J; Eilers PH; Tollenaar RA; de Graaf EJ; van't Slot R; Wijmenga C; Morreau H; van Wezel T
    Cancer Res; 2005 Nov; 65(22):10188-91. PubMed ID: 16288005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Epigenomic variations manifesting as a loss of heterozygosity affecting imprinted genes represent a molecular mechanism of autism spectrum disorders and intellectual disability in children].
    Iourov IY; Vorsanova SG; Zelenova MA; Vasin KS; Kurinnaia OS; Korostelev SA; Yurov YB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(5):91-97. PubMed ID: 31317896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.
    Carén H; Erichsen J; Olsson L; Enerbäck C; Sjöberg RM; Abrahamsson J; Kogner P; Martinsson T
    BMC Genomics; 2008 Jul; 9():353. PubMed ID: 18664255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Single nucleotide polymorphism microarray analysis of genetic alterations in cancer.
    Mullighan CG
    Methods Mol Biol; 2011; 730():235-58. PubMed ID: 21431646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SNP arrays: comparing diagnostic yields for four platforms in children with developmental delay.
    D'Amours G; Langlois M; Mathonnet G; Fetni R; Nizard S; Srour M; Tihy F; Phillips MS; Michaud JL; Lemyre E
    BMC Med Genomics; 2014 Dec; 7():70. PubMed ID: 25539807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How well do HapMap SNPs capture the untyped SNPs?
    Tantoso E; Yang Y; Li KB
    BMC Genomics; 2006 Sep; 7():238. PubMed ID: 16982009
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ATRIUM: testing untyped SNPs in case-control association studies with related individuals.
    Wang Z; McPeek MS
    Am J Hum Genet; 2009 Nov; 85(5):667-78. PubMed ID: 19913122
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An integrated Bayesian analysis of LOH and copy number data.
    Rancoita PM; Hutter M; Bertoni F; Kwee I
    BMC Bioinformatics; 2010 Jun; 11():321. PubMed ID: 20550648
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Allelic loss of 6q16.3 microsatellite DNA in childhood acute lymphoblastic leukemia and bioinformatics analysis].
    Yang MH; Cao LZ; Yu Y; Zhang ZX; Wang Y; Kang R; Chen Y; Tan ZH; Wu XS
    Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):289-93. PubMed ID: 16875573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Childhood acute lymphoblastic leukemia: is there a tumor suppressor gene in chromosome 12p12.3?
    Aïssani B; Bonan C; Baccichet A; Sinnett D
    Leuk Lymphoma; 1999 Jul; 34(3-4):231-9. PubMed ID: 10439360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays.
    George RE; Attiyeh EF; Li S; Moreau LA; Neuberg D; Li C; Fox EA; Meyerson M; Diller L; Fortina P; Look AT; Maris JM
    PLoS One; 2007 Feb; 2(2):e255. PubMed ID: 17327916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers.
    Wang ZC; Lin M; Wei LJ; Li C; Miron A; Lodeiro G; Harris L; Ramaswamy S; Tanenbaum DM; Meyerson M; Iglehart JD; Richardson A
    Cancer Res; 2004 Jan; 64(1):64-71. PubMed ID: 14729609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genome-wide detection of LOH in prostate cancer using human SNP microarray technology.
    Dumur CI; Dechsukhum C; Ware JL; Cofield SS; Best AM; Wilkinson DS; Garrett CT; Ferreira-Gonzalez A
    Genomics; 2003 Mar; 81(3):260-9. PubMed ID: 12659810
    [TBL] [Abstract][Full Text] [Related]  

  • 55. aCNViewer: Comprehensive genome-wide visualization of absolute copy number and copy neutral variations.
    Renault V; Tost J; Pichon F; Wang-Renault SF; Letouzé E; Imbeaud S; Zucman-Rossi J; Deleuze JF; How-Kit A
    PLoS One; 2017; 12(12):e0189334. PubMed ID: 29261730
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pediatric precursor T lymphoblastic leukemia and lymphoblastic lymphoma: Differences in the common regions with loss of heterozygosity at chromosome 6q and their prognostic impact.
    Burkhardt B; Moericke A; Klapper W; Greene F; Salzburg J; Damm-Welk C; Zimmermann M; Strauch K; Ludwig WD; Schrappe M; Reiter A
    Leuk Lymphoma; 2008 Mar; 49(3):451-61. PubMed ID: 18297521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
    Pollock PM; Welch J; Hayward NK
    Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel tagging SNP rs1495741 and 2-SNPs (rs1041983 and rs1801280) yield a high prediction of the NAT2 genotype in HapMap samples.
    He YJ; Shapero MH; McLeod HL
    Pharmacogenet Genomics; 2012 Apr; 22(4):322-4. PubMed ID: 22414877
    [No Abstract]   [Full Text] [Related]  

  • 59. Extensive loss of heterozygosity is suppressed during homologous repair of chromosomal breaks.
    Stark JM; Jasin M
    Mol Cell Biol; 2003 Jan; 23(2):733-43. PubMed ID: 12509470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.